Recently, a glutamate/cystine antiporter system that favors GSH synthesis in ROS was described in malignant lung cells [74] and it has been found that the transporter xCT is increased in monocytes from COVID-19 patients [51], suggesting that cystine has probably a role in immunity [75]. Here, SLC7A11 is linked to COVID-19.